A comprehensive review on the role of plant-derived bioactive metabolites driving ROS-mediated apoptosis in cancer

Canivizhi Vidjeyamannane1, Alan Joy1, Kishore Prakash1

  • 1Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, 603 203, India.

Insights

Natural compounds can selectively induce cancer cell death by regulating Reactive Oxygen Species (ROS). This review explores their mechanisms, therapeutic potential, and challenges for cancer treatment.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Reactive Oxygen Species (ROS) play a dual role in cancer, inducing cell death via oxidative stress and DNA damage.
  • Natural bioactive compounds offer selective ROS modulation for cancer therapy, targeting cancer cells while sparing normal cells.

Purpose of the Study:

  • To summarize the molecular mechanisms of ROS-induced apoptosis in cancer.
  • To review natural bioactive molecules with anticancer activity via ROS induction.
  • To discuss therapeutic applications and clinical translation challenges of these compounds.

Main Methods:

  • Literature review of studies on ROS, apoptosis, and natural bioactive compounds.
  • Analysis of molecular pathways involved in ROS-induced cancer cell death.
  • Evaluation of the therapeutic potential and limitations of natural compounds.

Main Results:

  • Natural compounds like polyphenols, flavonoids, alkaloids, and terpenoids induce apoptosis through mitochondrial damage and pathway modulation.
  • These compounds show potential in enhancing standard cancer therapies and overcoming drug resistance.
  • Clinical translation is challenged by issues of bioavailability, stability, and targeted delivery.

Conclusions:

  • ROS-modulating natural compounds represent a promising therapeutic strategy for cancer.
  • Understanding their mechanisms is key to developing effective cancer treatments.
  • Further research is needed to address clinical translation challenges for these bioactive compounds.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...